4//SEC Filing
Kulkarni Sandeep Chidambar 4
Accession 0001827506-24-000076
CIK 0001827506other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:22 PM ET
Size
5.8 KB
Accession
0001827506-24-000076
Insider Transaction Report
Form 4
Kulkarni Sandeep Chidambar
DirectorCEO
Transactions
- Purchase
Common Stock
2024-08-21$14.85/sh+1,779$26,418→ 7,000 total(indirect: By Gilead Capital, LP)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.82 to $14.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by Gilead Capital, LP ("Gilead"). The Reporting Person's spouse is a partner of Gilead and shares voting and investment power with respect to the shares held by Gilead, and therefore the Reporting Person may be deemed an indirect beneficial owner of these shares. This report is not an admission that the Reporting Person is an indirect beneficial owner of these shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Tourmaline Bio, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001945691
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:22 PM ET
- Size
- 5.8 KB